Onconova Therapeutics Inc

NASDAQ:ONTX   3:54:34 PM EDT
1.12
+0.04 (+3.70%)
Earnings Announcements

Onconova Therapeutics Reports Q1 2022 Financial Results

Published: 05/11/2022 20:53 GMT
Onconova Therapeutics Inc (ONTX) - Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Onconova Therapeutics Inc - Cash and Cash Equivalents As of March 31, 2022, Were $50.8 Million.
Onconova Therapeutics Inc - Net Loss for Q1 of 2022 $0.20 per Share.
Onconova Therapeutics - Believes Cash and Cash Equivalents Sufficient to Fund Ongoing Clinical Trials & Business Operations for at Least 18 Months.
Revenue is expected to be $0.07 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0.07 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.